Significantly higher levels of galectin-3 were also found in patients with osteosarcoma, and the authors assume that serum galectin-3 could serve as a useful biomarker for the evaluation of osteosarcoma progression [11]. The gene discussed is LGALS3; the disease is osteosarcoma.